Raedler, L. A. (2016). Aripiprazole Lauroxil (Aristada): Long-Acting Atypical Antipsychotic Injection Approved for the Treatment of Patients with Schizophrenia. Am Health Drug Benefits.
Citação norma ChicagoRaedler, Lisa A. "Aripiprazole Lauroxil (Aristada): Long-Acting Atypical Antipsychotic Injection Approved for the Treatment of Patients With Schizophrenia." Am Health Drug Benefits 2016.
MLA CitationRaedler, Lisa A. "Aripiprazole Lauroxil (Aristada): Long-Acting Atypical Antipsychotic Injection Approved for the Treatment of Patients With Schizophrenia." Am Health Drug Benefits 2016.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.